---
figid: PMC9694538__metabolites-12-01047-g003
pmcid: PMC9694538
image_filename: metabolites-12-01047-g003.jpg
figure_link: /pmc/articles/PMC9694538/figure/metabolites-12-01047-f003/
number: Figure 3
figure_title: ''
caption: Outline of HCT116 cancer metabolic profile based on OPLS-DA scores scatter
  plot visualization. Results from the raw spectra processing. (a) 0.75 µg/mL of DOX;
  (b) 1.5 µg/mL of DOX; (c) 7.5 µg/mL of DOX-treated HCT116 cells. The pink and green
  circles indicate control and DOX-treated cancer cells, respectively. Two-Dimensional
  OPLS-DA score plot in HCT116 cancer metabolic profile visualization. (d) R2 and
  Q2 performance analysis. A red asterisk indicates the highest expression of Q2 values
  of components.
article_title: Metabolomic Signatures in Doxorubicin-Induced Metabolites Characterization,
  Metabolic Inhibition, and Signaling Pathway Mechanisms in Colon Cancer HCT116 Cells.
citation: Raja Ganesan, et al. Metabolites. 2022 Nov;12(11):1047.
year: '2022'

doi: 10.3390/metabo12111047
journal_title: Metabolites
journal_nlm_ta: Metabolites
publisher_name: MDPI

keywords:
- HCT116 cells
- doxorubicin
- colorectal cancer
- NMR
- metabolomics
- metabolic profiling

---
